Global vaccine confidence trends among adults above and below age 65.

Publication date: Jul 21, 2025

This study is interested in global vaccine confidence because it directly impacts vaccination rates and public health outcomes, especially during the COVID-19 pandemic. Furthermore, due to the unique vulnerabilities to vaccine-preventable diseases, misinformation, and access to health information among adults aged 65 and older, understanding vaccine confidence in this population is crucial for developing targeted interventions and improving vaccination rates. The current research is limited by single-country surveys and cross-sectional designs, providing limited insights into these issues. We compared the vaccine confidence between the population over 65 and under 65 in terms of vaccine safety, effectiveness, compatibility with religious beliefs, and importance to children. We employed a hierarchical logistic model, and compared human development index (HDI) values to investigate determinants of vaccine confidence. Vaccine confidence increased between 2015 and 2019, but decreased between 2019 and 2022 across most global regions, exhibiting an inverted U-shaped trend. Population over 65 in high-income countries was more likely to agree on the safety, effectiveness, importance to children, and compatibility of vaccines with religious beliefs than those under 65, with agreement levels exceeding 80% for most aspects. Gender, education, income, and religion influenced vaccine attitudes among adults aged 65 and older. Countries with an HDI exceeding 0. 9 consistently demonstrated positive trends in vaccine confidence. This relationship between HDI and vaccine confidence underscores the importance of comprehensive societal development in shaping attitudes toward vaccination. These findings can help develop targeted interventions and policies to improve vaccination rates among older adults.

Open Access PDF

Concepts Keywords
Adults Adults
Global Aged
Misinformation Confidence
Vaccine Global
Hdi
Importance
Interventions
Older
Population
Rates
Targeted
Trends
Vaccination
Vaccine
Vaccines

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH vaccine-preventable diseases
disease IDO country
drug DRUGBANK Troleandomycin
disease MESH communicable diseases
disease IDO role
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Coenzyme M
disease MESH morbidity
disease MESH education level
disease IDO intervention
disease MESH retirement
disease IDO process
drug DRUGBANK Trestolone
disease IDO susceptibility
disease MESH dengue
disease MESH emergencies
drug DRUGBANK Spinosad
disease MESH uncertainty
disease MESH causes
disease IDO healthcare facility
disease MESH measles
pathway KEGG Measles
disease MESH pertussis
pathway KEGG Pertussis
disease MESH influenza
disease MESH polio
pathway KEGG Coronavirus disease
drug DRUGBANK Ivermectin
pathway REACTOME Reproduction

Original Article

(Visited 4 times, 1 visits today)